Ekspresja metalotioneiny i jej korelacja z antygenem Ki-67 w gruczolakorakach gruczolu sutkowego suk

• Autorzy: Nowak M , Madej J.A. , Dziegiel P.

Warianty tytułu

EN

Expression of metallothionein and its correlation with Ki-67 antigen in bitch's mammary gland adenocarcinomas

• Języki publikacji: PL

Abstrakty

EN

The aim of the research was to show the immunocytochemical expression of MT and Ki-67 and the correlation between these markers in spontaneous epithelium mammary gland cancer in bitches. The samples used in the research were extracted during surgical procedures from 20 bitches of different breeds, ranging from 6 to 15 years of age who had been diagnosed with mammary gland tumors. The prepared samples were then photographed with a microscope, to be later analyzed by a workstation comprised of a computer hooked up to a Carl Zeiss microscope model: Axiophot. The workstation was able to register images and then digitally analyze them. The MultiScaneBase V 8.08 program working on a Microsoft Windows platform was used to gather readings. The average correlation value between the Ki-67 and MT expression confirmed by many tests indicated a high index value of Ki-67 antigen as the prognostic agent. The study concluded that the presence of metalotionein in adenocarcinamas of the mammary gland in bitches does not indicate its connection with an increased proliferation potential of the cancer cells as is in the case in womens mammary gland tumors.

Słowa kluczowe

PL

korelacja; nowotwory; psy; antygen Ki-67; metalotioneina; gruczolakorak; suki; ekspresja; nowotwory gruczolu sutkowego

• Wydawca: -
• Czasopismo: Medycyna Weterynaryjna
• Rocznik: 2006
• Tom: 62
• Numer: 04
• Opis fizyczny: s.427-431,rys.,fot.,tab.,bibliogr.

Twórcy

autor

Nowak M

• Akademia Rolnicza, ul.Norwida 31, 50-375 Wroclaw

autor

Madej J.A.

autor

Dziegiel P.

Bibliografia

• 1.Arnesen K., Gamlem H., Glattre E., Moe L., Nordstoga K.: Registration of canine cancer. Tidsskr Nor Laegeforen 1995, 115, 714-717.
• 2.Barnard N. J., Hall P. A., Lemoine N. R., Kadarr N.: Proliferative index in breast carcinoma determined in situ by Ki-67 immunostaining and its relationship to clinical and pathological variables. J. Path. 1987, 152, 287-295.
• 3.Beyersman D., Haase H.: Functions of zinc in signaling, proliferation and differentiatin of mammalian cells. Bio Metals 2001, 14, 331-341.
• 4.Boon-Haut B., Jin R., Jayasura A.: Analysis of metallothionein expressin in human cancers. Acta Histochem. Cytochem. 2001, 34, 171-176.
• 5.Brown D. C., Gatter K. C.: Monoclonal antibody Ki-67: its use in histopathology. Histopathology 1990, 17, 489-503.
• 6.Cai L., Koropatnick J., Cherian M. G.: Metallothionein products DNA from copper induced but not iron induced cleavage in vitro. Chemico-Biol. Interact 1995, 96, 143-155.
• 7.Cardoso S. V., Caliari M. V., de Aguiar M. C., Cassali G. D.: Immunohistochemical staining of metallothionein in canine mammary tumors: better survival with higher expression. Oncol. Rep. 2004, 12, 1317-1321.
• 8.Cherian M. G., Apostolova M. D.: Nuclear localization of metallothionein during cell proliferation and differentiation. Cell Mol. Biol. 2000, 46, 347-356.
• 9.Coyle P., Philcox J. C., Carey L. C., Rofe A. M.: Metallothionein: The multipurpose protein. Cell Mol Life Sci. 2002, 59, 627-647.
• 10.Destexhe E., Lespagnard L., Degeyter M., Heymann R., Coignoul F.: Immunohistochemical identification of myoepithelial, epithelial, and connective tissue cells in canine mammary tumors. Vet. Path. 1993, 30, 146-154.
• 11.Dincer Z., Jasani B., Haywood S., Mullins J. E., Funtealba I. C.: Metallothionein expression in canine and feline mammary and melanotic tumours. J. Comp. Path. 2001, 125, 130-136.
• 12.Dzięgiel P.: Expression of Metallothioneins in Tumor Cells. Pol. J. Path. 2004, 55, 3-12.
• 13.Elis O., Pinder S. E., Lee A. S., Elston C. W.: Tumors of the breast, [w:] Fletcher C. D. M.: Diagnostic Histopathology of Tumors. Churchill, Livingstone, London 2000, 865-930.
• 14.Fuentealba I. C., Mullins J. E.: Immunohistochemical demonstration of metallothionein in benign and malignant canine mammary tumours. Histol. Histopathol. 1999, 14, 51-61.
• 15.Gerdes J., Shwab U., Lemke H., Baisch H., Wacker H. H.: Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated witch cell proliferation. Int. J. Canc. 1983, 31, 13-20.
• 16.Giziñski S., Boryczko Z., Katkiewicz M., Bostedt H.: Białko Ki-67 jako wskaźnik prognostyczny w nowotworach gruczo³u mlekowego u suk. Medycyna Wet. 2003, 59, 888-891. 17.Haq F., Mahoney M., Koropatnik J.: Signalling events for metallothionein induction. Mutat. Res. 2003, 533, 211-226.
• 18.Hishikawa Y., Kohno H., Ueda S., Kimoto T., Dhar D. K., Kubota H., Tachibana M., Koji T., Nagasue N.: Ekspression of metallothionein in colorectal cancers and synchronous liver metastases. Oncology 2001, 61, 162-167.
• 19.Ioachim E., Goussia A. C., Agnantis N. J., Machera M., Tsianos E. V., Kappas A. M.: Prognostic evaluation of metallothionein expression in human colorectal neoplasms. J. Clin. Path. 1999, 52, 876-879
• 20.Jasani B., Schmid K. W.: Significance of metallothionein overexpression in human tumors. Histopathology 1997, 31, 211-214. 21.Jin R., Chow V. T., Tan P. H., Dheen S. T., Duan W., Bay B. H.: Metallothionein 2 A expression is associated with cell proliferation in breast cancer. Carcinogenesis 2002, 23, 81-86.
• 22.Jin R., Bay B. H., Chow V. T., Tan P. H.: Metallothionein 1F mRNA expression correlates with histological grade in breast carcinoma. Breast Cancer Res. Treat 2001, 66, 265-272.
• 23.Kagi J. H. R., Himmelhoch S. R.: Equine hepatic and renal metallothioneinen. J. Biol. Chem. 1974, 249, 3537-3542.
• 24.Kloth D. M., Chin J. L., Cherian M. G.: Induction of hepatic metallothionein I in tumour-bearing mice. Br. J. Cancer 1995, 71, 712-716.
• 25.Madej J., Milnerowicz H., Dzimira S.: Immunohistochemiczna lokalizacja metalotioneiny (MT) w nowotworach nabłonkowych u zwierząt. Medycyna Wet. 1999, 55, 806-808.
• 26.Palmiter R. D.: Molecular biology of metallothionein gene expression. Experientia Suppl. 1987, 52, 63-80.
• 27.Remmele W., Stegner H. E.: Vorschlag zur einheitlichen Definition eines immunoreaktiven Score (IRS) für den immunohistochemichen Ostrogerezeptor-Nachweis (ER-ICA) im Mammakarzinomgewebe. Pathologie 1987, 8, 138-140.
• 28.Romero-Isart N., Vasak M.: Advances in the structure and chemistry of metallothioneins. J. Inoring Biochem. 2002, 88, 388-396.
• 29.Sato M., Bremmer I.: Oxygen free radicals and metallothionein. Free Rad. Biol. Med. 1993, 14, 325-337.
• 30.Satoh M., Naganuma A., Imura N.: Modulation of adriamycin toxicity by tissue-specific induction of metallothionein synthesis in mice. Life Sci. 2000, 67, 627-634.
• 31.Simpkins C. O.: Metallothionein in human disease. Cell Mol. Biol. 2000, 46, 465-488.
• 32.Sone T., Koizumi S., Kimura M.: Cadmium induced synthesis of metallothionein in human lymphocytes and monocytes. Chem. Biol. Interact 1988, 66, 61-70.
• 33.Szilagyi Z., Fenselau C.: Molecular dynamics simulation of metallothionein drug complexes. Drug Metab. Dispos. 2000, 2, 174-179.
• 34.Vasak M., Hasler D. W.: Metallothioneins: new functional and structural insights. Curr Opin. Chem. Biol. 2000, 4, 177-183.
• 35.Vazquez-Ramirez F. J., Gonzalez-Campora J. J., Hevia-Alvarez E., Fernandez-Santos J. M., Rios-Martin J. J., Otal-Salaverii C., Gonzalez-Campora R.: P-glycoprotein, metallothionein and NM23 protein expression in breast carcinoma. Path. Res. Pract. 2000, 196, 553-559.
• 36.Wirigley E., Verspaget H. W., Jayson G. C., McGown A. T.: Metallothionein ekspression in epithelial ovarian cancer: effect of chemotherapy and prognostic significance. J. Cancer Res. Clin. Oncol. 2000, 126, 717-721.
• 37.Zhang R., Wei H., Luo X.: Expression of metallothionein in invasive ductal breast cancer in relation to prognosis. J. Environ. Path. 2000, 19, 95-97.